Micra Accelerometer Sensor Study 2 (MASS2)
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
A NA clinical study on Bradyarrhythmia, this trial is completed. The trial is conducted by Medtronic Cardiac Rhythm and Heart Failure and has accumulated 10 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Apr 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Apr 2019 [monthly]
Completed NA
-
Jul 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Apr 2017 — Jul 2017 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting · Phase: PHASE2 → NA
-
Jan 2017 — Apr 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiac Rhythm and Heart Failure
For direct contact, visit the study record on ClinicalTrials.gov .